Literature DB >> 7131034

The effects of the increase of arterial potassium upon the excitability of normal and dystrophic myotonic muscles in man.

L Durelli, R Mutani, F Fassio, M Delsedime.   

Abstract

Progressively increasing concentrations of potassium chloride were administered intra-arterially to patients affected with dystrophia myotonica (Steinert's disease) and to healthy volunteers before and after parenteral taurine treatment. Changes in the excitability of thenar eminence muscles were related to plasma potassium concentrations. A rise in the plasma potassium brought about a parallel increase of muscular excitability in normal individuals whilst in dystrophic myotonic patients it was associated with a two-phase phenomenon: the severity of myotonia first decreased and then, at higher plasma potassium levels, greatly worsened with the occurrence of spontaneous myotonic discharges. The administration of taurine, a membrane-stabilizing drug, considerably lowered the excitability of both normal and dystrophic myotonic muscles. The effects of potassium and taurine on muscular membrane conductance may explain the observed changes in muscular excitability.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7131034     DOI: 10.1016/0022-510x(82)90123-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Continuous infusion of propofol in dystrophia myotonica.

Authors:  D A White; D G Smyth
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

Review 2.  Regulation of muscle potassium: exercise performance, fatigue and health implications.

Authors:  Michael I Lindinger; Simeon P Cairns
Journal:  Eur J Appl Physiol       Date:  2021-01-04       Impact factor: 3.078

3.  Deficiency of Na+/K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase in skeletal muscle and cultured muscle cells of myotonic dystrophy patients.

Authors:  A A Benders; J A Timmermans; A Oosterhof; H J Ter Laak; T H van Kuppevelt; R A Wevers; J H Veerkamp
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.